Animalcare Group Future Growth
Future criteria checks 1/6
Animalcare Group is forecast to grow earnings and revenue by 15.8% and 3.8% per annum respectively.
Key information
15.8%
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 19.4% |
Revenue growth rate | 3.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 24 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 81 | 9 | 8 | 15 | 2 |
12/31/2025 | 78 | 8 | 7 | 14 | 2 |
12/31/2024 | 74 | 8 | 7 | 12 | 2 |
6/30/2024 | 76 | 5 | 10 | 13 | N/A |
3/31/2024 | 75 | 3 | 9 | 12 | N/A |
12/31/2023 | 74 | 1 | 8 | 11 | N/A |
9/30/2023 | 71 | 1 | 9 | 11 | N/A |
6/30/2023 | 69 | 1 | 9 | 11 | N/A |
3/31/2023 | 70 | 2 | 8 | 10 | N/A |
12/31/2022 | 72 | 2 | 7 | 9 | N/A |
9/30/2022 | 72 | 2 | 7 | 9 | N/A |
6/30/2022 | 73 | 2 | 7 | 9 | N/A |
3/31/2022 | 74 | 1 | 9 | 12 | N/A |
12/31/2021 | 74 | 0 | 11 | 14 | N/A |
9/30/2021 | 75 | 0 | 11 | 14 | N/A |
6/30/2021 | 75 | 0 | 11 | 14 | N/A |
3/31/2021 | 73 | 0 | 10 | 13 | N/A |
12/31/2020 | 70 | 0 | 9 | 11 | N/A |
9/30/2020 | 70 | 0 | 9 | 11 | N/A |
6/30/2020 | 70 | 1 | 9 | 11 | N/A |
3/31/2020 | 70 | 0 | 10 | 12 | N/A |
12/31/2019 | 71 | -1 | 11 | 13 | N/A |
9/30/2019 | 72 | -2 | 9 | 12 | N/A |
6/30/2019 | 73 | -3 | 7 | 11 | N/A |
3/31/2019 | 73 | -1 | 5 | 9 | N/A |
12/31/2018 | 72 | 0 | 3 | 7 | N/A |
9/30/2018 | 72 | 0 | 0 | 4 | N/A |
6/30/2018 | 72 | 0 | -2 | 1 | N/A |
3/31/2018 | 67 | 0 | N/A | 2 | N/A |
12/31/2017 | 62 | 0 | N/A | 2 | N/A |
12/31/2016 | 68 | 4 | N/A | 9 | N/A |
12/31/2015 | 47 | -1 | N/A | -1 | N/A |
12/31/2014 | 34 | 1 | N/A | 2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WQ7's forecast earnings growth (15.8% per year) is above the savings rate (0.8%).
Earnings vs Market: WQ7's earnings (15.8% per year) are forecast to grow slower than the German market (20% per year).
High Growth Earnings: WQ7's earnings are forecast to grow, but not significantly.
Revenue vs Market: WQ7's revenue (3.8% per year) is forecast to grow slower than the German market (5.5% per year).
High Growth Revenue: WQ7's revenue (3.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if WQ7's Return on Equity is forecast to be high in 3 years time